Loading clinical trials...

Post-licensure Safety Study of IMOJEV® in Thailand | Clinical Trials | Clareo Health

COMPLETEDPhase 4NCT01981967

Post-licensure Safety Study of IMOJEV® in Thailand

The aim of this study is to further characterize the safety profile of IMOJEV®. Primary Objective: * To describe serious adverse events (SAEs, including adverse events of special interest \[AESIs\])...

Lead sponsor: Sanofi Pasteur, a Sanofi Company•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization

NCT06372665 · Japanese Encephalitis

COMPLETEDNA

Flavivirus Cross-priming Potential of IMOJEV

NCT03920111 · Japanese Encephalitis

COMPLETEDPhase 3

Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

NCT00594958 · Japanese Encephalitis

COMPLETEDPhase 3

Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

NCT00605085 · Japanese Encephalitis

UNKNOWNPhase 4

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

NCT04817917 · Japanese Encephalitis, Vaccine Preventable Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 4, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment10,000

Start dateNov 2013

Last updatedMay 4, 2016

Condition

Japanese Encephalitis

Locations shown

Bangkok

Chiang Mai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 4, 2016Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions